Thus, targeting the TREM2-DAP12-SYK pathway in macrophages not only affects lipid droplet formation in adipose tissue but also modulates the body’s response to HFDs, potentially mitigating obesity progression at its core. Here, TREM2 is linked to obesity disorder.